We promised we'd give you a full recap of our Dating Game at #DPharm2024, and here it is! 🎉 "It's cold. It's lonely out there." 🥶Nichole Gallatti, our brave site representative, has kissed a lot of frogs in the world of clinical trials, trying to find her Sponsor of Choice. Three industry heavyweights Stephen Ruhmel Marie Emms and Nicole Sheetz stepped up to win her heart (and make clinical trials a whole lot smoother). From tech overload to protocol simplification, how did they address the toughest challenges Nichole faces? Read about what she’s looking for - and see if you could have matched! 💕 Link in comments 👇 #ClinicalTrials #SiteBurden #PharmaSponsors #Dpharm
About us
ProofPilot is a digital protocol automation platform and a clinical trial solution created for life science companies that eliminates guesswork and research protocol deviations to create high-performance experiences for your sites and patients.
- Website
-
http://proofpilot.com/
External link for ProofPilot
- Industry
- Software Development
- Company size
- 11-50 employees
- Headquarters
- New York
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Research, Research Data Collection, Research Participant Recruitment, Longitudinal Research, Pharma, clinical research, automation, digital health, sensor research, workflow orchestration, decentralized trials, digital protocol, EMR integration, patient retention, site engagement, Protocolautomation, protocolguidance, knowledgebase, patientcentric, and sitecentric
Locations
-
Primary
New York, US
Employees at ProofPilot
Updates
-
📢 Update from the Innovation Network Gathering Our Chief Strategy Officer Joseph K. just attended a session led by Bill Illis from Novartis, where he addressed a critical issue in clinical trials: protocol failure caused by overreliance on paper protocols. ⛔ 💡 It's clear that outdated processes are holding trials back. By simplifying the most complex of studies, sites can remain compliant with study protocols, leading to fewer errors, better data, and less work for sponsors. #ING2024 #ClinicalTrials #ProtocolCompliance #ProtocolAdherence #PaperProtocols
-
🎥 Roll out the red carpet... literally! We had a blast welcoming attendees at #SCRSGlobal2024 with our very own red carpet treatment, glowing up the crowd! There's one star we couldn’t identify in the video – can YOU help us? 🤔 Watch the reel and let us know who our mystery guest is. First person to solve the puzzle gets a free drink on Joseph K. at the next event! 🍻🍹🥃 Thanks again for hosting Society for Clinical Research Sites (SCRS) TransCelerate BioPharma Inc.🙏🙏 #SCRS #SCRS2024 #SCRSsitesolutionssummit
-
We made it to Florida for the Society for Clinical Research Sites (SCRS) Global Summit despite Hurricane Helene! For those who couldn’t attend due to the storm, we got some recap for you! One of the top challenges sites still face today, as highlighted by #SCRS, is failing to meet enrollment and diversity targets. Reducing site burden gives them more time to properly recruit patients. ⏳ Our CSO, Joseph K., hosted The Newlywed Game: Recruitment Struggles & Modern Solutions, breaking down recruitment myths and highlighting real-world solutions. Some mind-blowing insights from the session: 😱 Site burden: Some sites reported spending anywhere from 5 to 280 hours per week playing phone tag with potential participants - one even employed 7 full-time staff just for this! 📞 Side note: our Calendar Sync feature allows patients to instantly book that 1st call with the site, eliminating phone tags, and boosting conversion rates by over 350% - learn more https://lnkd.in/eY62tmN4. 🧩 Patient recruitment: When faced with two competing studies, sites will redirect 60% to 100% of their patients into the study that’s easier to run. 🎯 Central recruitment campaigns: Sponsors expect these campaigns to account for 15-35% of patient enrollment, yet they often underperform due to poor referral quality, limited bandwidth, ineffective content, and inaccurate targeting. 📃 Data return to patients: If patients want their data, why aren’t sites giving it to them? Lack of resources plays a part, but more simply, there is just no data to share! To learn more about data return challenges and solutions, check out this blog https://lnkd.in/eKAq8zKP. 🙏 A huge thank you to Amanda Decoker, Carla Arzuaga Sheppard, Joe O'Rourke, Louisa Khalil, Nicole S., and Steven Geller, for participating! For those interested in optimizing patient recruitment, ProofPilot is known to shorten recruitment timelines by 30% through efficient screening, simplified communications, and comprehensive support. #SCRS2024 #SiteBurden #ClinicalTrials #ClinicalResearch #PatientRecruitment #DataReturn #ReturnofResults TransCelerate BioPharma Inc.
-
+5
-
🎤 We're live from the Society for Clinical Research Sites (SCRS) Global Site Solutions Summit! Once again, recruitment and tech management round out the top 3 issues sites are facing. The good news? 🎉 Sponsors are partnering with #ProofPilot to tackle these challenges head-on and transform the clinical experience for sites! Joseph K. and Mariko Longley are roaming around SCRS, interviewing sites live - so if you’ve got a bone to pick, find them! #SCRS #ClinicalResearch #SiteChallenges #ClinicalTrials #PatientRecruitment
-
👫 Can’t get enough of The Dating Game at #DPHARM2024? Join us at the Society for Clinical Research Sites (SCRS) Global Site Solutions Summit this Saturday, September 28th, from 4:00-5:00 PM for The Newlywed Game: Recruitment Struggles & Modern Solutions! When traditional recruitment methods are exhausted, it’s time for something fresh. We’re taking a fun, Newlywed Game-style approach to debunk old conventions and explore strategies that go beyond the usual. Learn from both industry pros and sites, as we reveal the truth behind what actually works - from digital platforms to targeted outreach. 🗣️ Facilitator: Joseph K., Chief Strategy Officer, ProofPilot 🌟 Panelists: Experts from Takeda Walgreens Clinical Trials Gilead Sciences, Javara, Atlas Clinical Research, and Lynn Institute See you there! #clinicaltrials #clinicaltrial #clinicalresearch #patientrecruitment #SCRS #sitesolutionssummit
-
🔥Say hello to our brand new website! We’ve given our site a futuristic makeover that’s as cool as it gets! Basically, it’s the glow-up you didn’t know you needed. 💥 🎬 New intro video: Want to know what #ProofPilot is all about in a flash? Our snazzy intro video has you covered. 💡 Solutions, unlocked: Get the lowdown on our products with shiny new breakdowns and descriptions – because who doesn’t love the details? 💻 New Platform & Compliance page: The boring stuff, but rest assured we’re fully committed to complying with global regulatory requirements. 🔍 Improved navigation: No more endless clicking! We’ve made it super easy to find exactly what you need. 📱 Mobile Magic: Whether you’re desk-bound or on the move, our mobile experience is slicker than ever. We’ve got you covered, wherever you roam. Come take a tour and see how we’re making clinical trials cool again 👉 www.proofpilot.com #ClinicalTrials #ClinicalExperience #CXP #ClinicalResearch #HealthTech
-
🌟 Happening now at the TransPerfect Life Sciences C3 Summit! Join us for the panel "Proven Practices That Move the Needle on Patient Recruitment & Retention." Our Chief Strategy Officer, Joseph K., and the expert panel are discussing key strategies for improving patient-centric approaches in clinical trials. Here’s a sneak peek of the live event. Head over in person to catch the full discussion! #C3Summit #PatientRecruitment #PatientRetention #ClinicalTrials
-
Will you be attending TransPerfect Life Sciences' #C3Summit in Princeton today? Our Chief Strategy Officer, Joseph K., and VP of Growth, Mariko Longley, will both be there! Joe will be speaking on two panels: 1️⃣ Proven Practices That Move the Needle on Patient Recruitment & Retention 🕒 1:30pm – 2:00pm 2️⃣ Patient-Focused Paradigm: Navigating Conversations, Challenges, and Outcomes in Engagement 🕒 3:15pm – 4:00pm If you're attending, be sure to catch these sessions and say hello! #C3Summit #ClinicalTrials #PatientEngagement #PatientRecruitment #PatientRetention
-
This was our third time attending DPHARM: Disruptive Innovations to Modernize Clinical Research and it never fails to fire us up. Here’s what stood out this year: 🏆Less burden, more wins: Site & patient efficiency Site burden remains as one of the main challenges we are facing. Leaders like Dennis Salotti and Brett Bishop (MSc, PhD) tackled workflow hurdles and recruitment snags. The key takeaway? Make things easier for sites and patients, and everyone wins. ⚕️Patient insights: The secret sauce Forget one-size-fits-all trials. Randy Krauss showed us how advanced analytics can power smarter study planning and site selection. But one of the most eye-opening moments came from Sarah Zenner-Dolan, a former Pharma exec diagnosed with Parkinson’s. As a trial participant, she realized just how critical clear information is for patients to engage effectively - setting expectations, preparing for visits, and resting appropriately. We agree!! 🌍 DEI: Enough talk, it's time for action Leaders like Bari Kowal, Deirdre BeVard, Angela DeLuca, Candice Fitzgerald, and Staci Hargraves are redefining what’s possible. By integrating AI and prioritizing the patient voice in trial design, they’re meeting and exceeding the latest #DEI guidelines. This isn’t just talk; it’s about creating real, impactful change and fostering environments where teams thrive and understand their roles in navigating the complexities of clinical operations. #OldDogNewTricks 🐾 Marland May, MS May surprised us with this one: late-stage physicians in their 50s and 60s, who've never done research, are diving into it to reignite their passion. Who knew? 💡Sites & patients deserve better Carrie Northcott’s session laid it out - sites and patients are asking for clear communication, fewer platforms, and easy data transfer. Instead, they’re getting chaos and burnout. Adding to this, Andy Lee pointed out how protocol complexity adds to site burden. Simplifying this could make a world of difference for both sites and patients. DPHARM showed us that it’s time to rethink, retool, and revamp how we approach clinical research. We’re here for it, and we know you are too! #DPHARM2024 #DPHARM #ClinicalTrials #ClinicalResearch #ClinicalInnovation #PatientRecruitment